Pacer Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.8M Buy
186,134
+183,268
+6,395% +$9.42M 0.02% 541
2026
Q1
$170K Buy
2,866
+1,542
+116% +$100K ﹤0.01% 1765
2025
Q4
$81.7K Sell
1,324
-139
-10% -$8.51K ﹤0.01% 2753
2025
Q3
$91.3K Sell
1,463
-1,094
-43% -$76.2K ﹤0.01% 2383
2025
Q2
$204K Sell
2,557
-494
-16% -$41.3K ﹤0.01% 1788
2025
Q1
$262K Sell
3,051
-301
-9% -$24.7K ﹤0.01% 1682
2024
Q4
$262K Buy
3,352
+1,520
+83% +$118K ﹤0.01% 1818
2024
Q3
$132K Buy
1,832
+432
+31% +$30.6K ﹤0.01% 1939
2024
Q2
$96.4K Buy
1,400
+69
+5% +$4.67K ﹤0.01% 2385
2024
Q1
$96.6K Buy
1,331
+889
+201% +$59.4K ﹤0.01% 2780
2023
Q4
$27.1K Buy
442
+204
+86% +$12.1K ﹤0.01% 3259
2023
Q3
$13.6K Sell
238
-31
-12% -$1.87K ﹤0.01% 2554
2023
Q2
$16K Buy
+269
New +$16.1K ﹤0.01% 3328
2021
Q1
Sell
-5,587
Closed -$195K 1544
2020
Q4
$195K Sell
5,587
-6,511
-54% -$231K ﹤0.01% 1249
2020
Q3
$441K Buy
+12,098
New +$450K 0.01% 1025
2020
Q1
Sell
-13,963
Closed -$566K 986
2019
Q4
$566K Sell
13,963
-5,189
-27% -$194K 0.03% 739
2019
Q3
$664K Sell
19,152
-1,461
-7% -$48.1K 0.01% 935
2019
Q2
$653K Buy
+20,613
New +$613K 0.02% 921
2018
Q4
Sell
-18,134
Closed -$687K 906
2018
Q3
$687K Buy
18,134
+2,061
+13% +$78K 0.03% 785
2018
Q2
$617K Buy
16,073
+1,746
+12% +$58.9K 0.03% 840
2018
Q1
$483K Buy
14,327
+1,513
+12% +$58.1K 0.03% 762
2017
Q4
$569K Buy
+12,814
New +$584K 0.04% 660

Other funds holding PBH

Pacer Advisors's PBH Position: Q2 2026 in Review

Pacer Advisors increased its Prestige Consumer Healthcare (PBH) stake by 6,395% in Q2 2026, buying an estimated $9.42M and bringing the position to 186,134 shares worth $8.8M. The position accounts for 0.02% of the portfolio, ranked #541.

Pacer Advisors first reported a position in PBH in Q4 2017 and has held it in 22 quarters since. 320 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Pacer Advisors held 186,134 shares of Prestige Consumer Healthcare worth $8.8M as of Q2 2026.
  • Pacer Advisors bought 183,268 Prestige Consumer Healthcare shares in Q2 2026, an estimated $9.42M.
  • Prestige Consumer Healthcare made up 0.02% of Pacer Advisors's portfolio in Q2 2026, its #541 holding.
  • Pacer Advisors first reported a position in Prestige Consumer Healthcare in Q4 2017 and has held it in 22 quarters since.
  • 320 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.